Enhanced erythropoiesis and iron metabolism

  • US 8,609,646 B2
  • Filed: 07/12/2010
  • Issued: 12/17/2013
  • Est. Priority Date: 06/06/2003
  • Status: Active Grant
First Claim
Patent Images

1. A method for decreasing hepcidin expression in a subject in need thereof, the method comprising administering to the subject an effective amount of a heterocyclic carboxamide compound that stabilizes the alpha subunit of hypoxia-inducible factor (HIFα

  • ), thereby decreasing hepcidin expression in the subject.

View all claims

    Thank you for your feedback